Literature DB >> 27061372

Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders.

M Pérez-Piñar1, R Mathur2, Q Foguet3, S Ayis4, J Robson2, L Ayerbe5.   

Abstract

BACKGROUND: The evidence informing the management of cardiovascular risk in patients with psychiatric disorders is weak.
METHODS: This cohort study used data from all patients, aged≥30, registered in 140 primary care practices (n=524,952) in London to estimate the risk of developing diabetes, hypertension, hyperlipidemia, tobacco consumption, obesity, and physical inactivity, between 2005 and 2015, for patients with a previous diagnosis of schizophrenia, depression, anxiety, bipolar or personality disorder. The role of antidepressants, antipsychotics and social deprivation in these associations was also investigated. The age at detection of cardiovascular risk factor was compared between patients with and without psychiatric disorders. Variables, for exposures and outcomes, defined from general practitioners records, were analysed using multivariate regression.
RESULTS: Patients with psychiatric disorders had an increased risk for cardiovascular risk factors, especially diabetes, with hazard ratios: 2.42 (2.20-2.67) to 1.31 (1.25-1.37), hyperlipidemia, with hazard ratios: 1.78 (1.60-1.97) to 1.25 (1.23-1.28), and obesity. Antidepressants, antipsychotics and social deprivation did not change these associations, except for smoking and physical inactivity. Antidepressants were associated with higher risk of diabetes, hypertension and hyperlipidemia. Antipsychotics were associated with a higher risk of diabetes. Antidepressants and antipsychotics were associated with lower risk of other risk factors. Patients with psychiatric conditions have later detection of cardiovascular risk factors. The interpretation of these results should acknowledge the lower rates of detection of risk factors in mentally ill patients.
CONCLUSIONS: Cardiovascular risk factors require special clinical attention among patients with psychiatric disorders. Further research could study the effect of antidepressants and antipsychotics on cardiovascular risk factors.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antidepressive agents; Antipsychotic agents; Cardiovascular diseases; Cohort studies; Schizophrenia; Socioeconomic factors

Mesh:

Substances:

Year:  2016        PMID: 27061372     DOI: 10.1016/j.eurpsy.2016.02.004

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  24 in total

1.  Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase®.

Authors:  Thi Thu Ha Nguyen; Anne Roussin; Vanessa Rousseau; Jean-Louis Montastruc; François Montastruc
Journal:  Drug Saf       Date:  2018-11       Impact factor: 5.606

Review 2.  Anxiety and Hypertension: Is There a Link? A Literature Review of the Comorbidity Relationship Between Anxiety and Hypertension.

Authors:  Heather M Johnson
Journal:  Curr Hypertens Rep       Date:  2019-07-18       Impact factor: 5.369

3.  Physical Illnesses Before Diagnosed as Schizophrenia: A Nationwide Case-Control Study.

Authors:  Yi-Lung Chen; Chun-Hung Pan; Chi-Kang Chang; Pao-Huan Chen; Hu-Ming Chang; Ming-Hong Tai; Sheng-Shiang Su; Shang-Ying Tsai; Chiao-Chicy Chen; Chian-Jue Kuo
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

Review 4.  Autonomic Neural Circuit and Intervention for Comorbidity Anxiety and Cardiovascular Disease.

Authors:  Xuanzhao Chen; Li Xu; Zeyan Li
Journal:  Front Physiol       Date:  2022-04-27       Impact factor: 4.755

Review 5.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

6.  Genetic investigations of 100 inherited cardiac disease-related genes in deceased individuals with schizophrenia.

Authors:  Sofie Lindgren Christiansen; Jeppe Dyrberg Andersen; Gonçalo Espregueira Themudo; Christin Løth Hertz; Johannes Rødbro Busch; Martin Roest Christensen; Kristine Boisen Olsen; Jytte Banner; Niels Morling
Journal:  Int J Legal Med       Date:  2021-05-11       Impact factor: 2.686

Review 7.  Cardiovascular risk assessment in patients with a severe mental illness: a systematic review and meta-analysis.

Authors:  Quintí Foguet-Boreu; Maria Isabel Fernandez San Martin; Gemma Flores Mateo; Edurne Zabaleta Del Olmo; Luís Ayerbe García-Morzon; Maria Perez-Piñar López; Luis Miguel Martin-López; Javier Montes Hidalgo; Concepción Violán
Journal:  BMC Psychiatry       Date:  2016-05-12       Impact factor: 3.630

Review 8.  The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysis.

Authors:  Virginio Salvi; Ilaria Grua; Giancarlo Cerveri; Claudio Mencacci; Francesco Barone-Adesi
Journal:  PLoS One       Date:  2017-07-31       Impact factor: 3.240

9.  Treatment following myocardial infarction in patients with schizophrenia.

Authors:  Rubina Attar; Martin Berg Johansen; Jan Brink Valentin; Jørgen Aagaard; Svend Eggert Jensen
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

10.  THE MANAGEMENT OF CARDIOVASCULAR DISEASE RISK FACTORS IN BIPOLAR DISORDER PATIENTS IN PRIMARY HEALTHCARE SETTINGS.

Authors:  Sandra I Ralat; Rossana I Barrios
Journal:  Rev Puertorriquena Psicol       Date:  2020 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.